Skip to main content
. 2021 May 23;225:108783. doi: 10.1016/j.drugalcdep.2021.108783

Fig. 1.

Fig. 1

Clinician-reported challenges patients have experienced regarding opioid use disorder treatment during the COVID-19 Public Health Emergency¥ (n = 7419).

Figure Footnotes.

¥Among clinicians prescribing buprenorphine for opioid use disorder treatment in the past 12 months.

Error bars represent 95 % confidence intervals.

Source: CDC-NIDA Survey of DATA 2000 Clinicians, June-August 2020.